Your browser doesn't support javascript.
loading
The implications of cardiac device cybersecurity responsibilities and challenges faced by policymakers, manufacturers, and patients.
Patel, Bhakti; Makaryus, Amgad N.
Afiliación
  • Patel B; Donald and Barbara Zucker School of Medicine, Hofstra/Northwell Health, Hempstead, NY, USA.
  • Makaryus AN; Donald and Barbara Zucker School of Medicine, Hofstra/Northwell Health, Hempstead, NY, USA.
Expert Rev Pharmacoecon Outcomes Res ; 24(6): 743-747, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38808954
ABSTRACT

INTRODUCTION:

As digital health expands, reliance on digital endpoints is rapidly increasing to improve diagnostic accuracy and management in the healthcare field. Digital endpoints are beneficial to monitor how patient's clinical information is processed outside of a clinical setting. AREAS COVERED Implications of cardiac digital endpoints play a role in allowing patients to track their clinical data outside of a clinical setting. Advances in cardiac digital endpoints involve advanced devices and implants, trackers, and artificial intelligence. We will explore further digital endpoints within cardiology and threats as well as security concerns for policies to focus on the maintenance of safe patient health data analysis, transmission, and processing. EXPERT OPINION As digital endpoints evolve and expand, policymakers must ensure there is adequate cybersecurity surrounding them. We believe guidelines should be in place to make sure data is accessed solely on a secure connection and access to digital literacy for patients should be readily available.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Seguridad Computacional Límite: Humans Idioma: En Revista: Expert Rev Pharmacoecon Outcomes Res Asunto de la revista: FARMACOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Seguridad Computacional Límite: Humans Idioma: En Revista: Expert Rev Pharmacoecon Outcomes Res Asunto de la revista: FARMACOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos